Oncology

reshuffle pipeline target reorganize shift change
Biotech

Recursion streamlines pipeline following merger with Exscientia

Evidently in the mood for spring cleaning, Recursion is clearing out part of its pipeline as it narrows its focus on oncology and rare diseases.
Fraiser Kansteiner May 5, 2025 11:00am
Caribou antlers sitting on ground with mountains in background

Caribou cuts 32% of staff, further purges cell therapy pipeline

Apr 24, 2025 9:55pm
Mosaic pattern collage

Mosaic licenses 2 clinical stage tumor drugs from Otsuka's Astex

Apr 24, 2025 10:00am
cellos without players

Bayer boosts precision oncology efforts with multiyear AI deal

Apr 23, 2025 12:55pm
medical data concept with hospital in the background

Tempus AI in line for $200M from AstraZeneca cancer model deal

Apr 23, 2025 9:01am
Glowing puzzle piece fitting into puzzle

Boehringer slots synthetic lethal program into oncology pipeline

Apr 23, 2025 7:45am
More News

Tempest lays off 80% of workforce to ride out cash crunch

Apr 21, 2025 8:20am

Flatiron Health, Massive Bio forge patient recruitment pact

Apr 9, 2025 12:47pm

ADCs to cell therapy: How AZ aims to 'redefine' oncology

Apr 9, 2025 11:44am

UK's Epsilogen acquires fellow immunoglobin biotech TigaTx

Apr 7, 2025 8:49am